Table 4.
Outcome for patients with ER positive tumors divided by different levels of PgR (IHC) expression and different time periods
| Tam vs. control | PgR (IHC) (%) | 0–5 years | Beyond 5 years | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of patients/events | HR (95 % CI) | p value | Number of patients/events | HR (95 % CI) | p value | ||||
| TAM | Control | TAM | Control | ||||||
| Recurrence rate | 0 | 79/4 | 82/13 | 0.29 (0.09–0.89) | 0.031 | 73/15 | 64/11 | 1.34 (0.62–2.93) | 0.46 |
| 1–9 | 25/2 | 25/2 | 1.07 (0.15–7.56) | 0.95 | 22/6 | 21/4 | 1.14 (0.32–4.05) | 0.85 | |
| 10–49 | 70/8 | 50/12 | 0.44 (0.18–1.07) | 0.069 | 59/6 | 37/15 | 0.21 (0.08–0.54) | 0.001 | |
| 50–74 | 63/2 | 52/10 | 0.15 (0.03–0.69) | 0.015 | 55/9 | 40/10 | 0.59 (0.24–1.46) | 0.26 | |
| ≥75 | 92/2 | 80/11 | 0.15 (0.03–0.67) | 0.013 | 85/16 | 66/14 | 0.93 (0.45–1.91) | 0.85 | |